Source: Brownstone Institute
by Joseph Varon
“Faced with one of the biggest and fastest changes in human health, we’re treating the results as a condition that needs lifelong medication. The newest drugs are very effective, and that’s important to recognize. Semaglutide and tirzepatide have led to weight loss that older nonsurgical treatments rarely matched. Semaglutide has also reduced the risk of major heart problems in people with overweight or obesity and heart disease who didn’t have diabetes. Tirzepatide has greatly improved sleep apnea in people with obesity. These results are significant, and these drugs are much more than cosmetic weight-loss aids. That’s why we need to look closely at what’s happening now. The problem isn’t that these drugs don’t work; they clearly do. The real concern is that they might work so well that we stop asking why so many people need them in the first place.” (10/07/26)
https://brownstone.org/articles/when-did-obesity-become-a-drug-deficiency/